← Back to Screener
Prenetics Global Limited Class A Ordinary Share (PRE)
Price$20.39
Value ScoreD
Growth ScoreD
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)47.89%
Price vs S&P 500 (4W)19.00%
VGM Score51.47
Market Capitalization$355.08M
All Metrics
Book Value / Share (Quarterly)$13.89
P/TBV (Annual)1.42x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-30.56%
Cash Flow / Share (Quarterly)$1.07
Price vs S&P 500 (YTD)23.03%
Gross Margin (TTM)60.90%
Net Profit Margin (TTM)-20.52%
EPS (TTM)$-2.74
10-Day Avg Trading Volume0.32M
EPS Excl Extra (TTM)$-2.74
Revenue Growth (5Y)58.62%
EPS (Annual)$-2.68
ROI (Annual)-23.83%
Gross Margin (Annual)53.54%
Net Profit Margin (5Y Avg)-92.87%
Cash / Share (Quarterly)$5.62
Revenue Growth QoQ (YoY)-89.62%
ROA (Last FY)-18.30%
Revenue Growth TTM (YoY)-77.95%
EBITD / Share (TTM)$-1.40
ROE (5Y Avg)-33.63%
Operating Margin (TTM)-54.41%
Cash Flow / Share (Annual)$-6.78
P/B Ratio2.27x
P/B Ratio (Quarterly)1.42x
Net Income / Employee (Annual)$-132,300
EV / Revenue (TTM)8.88x
Net Interest Coverage (TTM)-98.76x
ROA (TTM)-18.72%
EPS Incl Extra (Annual)$-2.68
Current Ratio (Annual)2.97x
Quick Ratio (Quarterly)2.72x
3-Month Avg Trading Volume0.24M
52-Week Price Return111.00%
Revenue / Employee (TTM)$128,300
Tangible BV / Share (Quarterly)$13.89
P/S Ratio (Annual)3.84x
Asset Turnover (Annual)0.45x
52-Week High$23.63
Operating Margin (5Y Avg)-54.23%
EPS Excl Extra (Annual)$-2.68
CapEx CAGR (5Y)77.92%
26-Week Price Return63.82%
Quick Ratio (Annual)2.37x
13-Week Price Return18.47%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)2.97x
Enterprise Value$324.72M
Revenue / Share Growth (5Y)39.53%
Asset Turnover (TTM)0.18x
Revenue / Employee (Annual)$324,200
Inventory Turnover (Annual)6.31x
Pretax Margin (Annual)-39.20%
Cash / Share (Annual)$5.62
3-Month Return Std Dev88.60%
Gross Margin (5Y Avg)37.09%
Net Income / Employee (TTM)$-132,300
ROE (Last FY)-24.10%
Net Interest Coverage (Annual)-18.51x
EPS Basic Excl Extra (Annual)$-2.68
Receivables Turnover (TTM)1.47x
EV / Free Cash Flow (TTM)40.84x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-2.74
Receivables Turnover (Annual)22.48x
ROI (TTM)-23.52%
P/S Ratio (TTM)9.71x
Pretax Margin (5Y Avg)-74.18%
Revenue / Share (Annual)$6.57
Tangible BV / Share (Annual)$13.89
Price vs S&P 500 (52W)82.79%
Year-to-Date Return33.97%
5-Day Price Return25.82%
EPS Normalized (Annual)$-2.68
ROA (5Y Avg)-48.57%
Net Profit Margin (Annual)-40.82%
Month-to-Date Return26.27%
Cash Flow / Share (TTM)$-2.78
EBITD / Share (Annual)$-3.01
Operating Margin (Annual)-48.14%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)21.78x
ROI (5Y Avg)-32.46%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.74
P/TBV (Quarterly)1.42x
P/B Ratio (Annual)1.42x
Inventory Turnover (TTM)6.31x
Pretax Margin (TTM)-26.42%
Book Value / Share (Annual)$13.89
Price vs S&P 500 (13W)8.73%
Beta0.20x
P/FCF (Annual)43.46x
Revenue / Share (TTM)$2.28
ROE (TTM)-23.96%
52-Week Low$5.58
vGradeD
gGradeD
mGradeA
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PREPrenetics Global Limited Class A Ordinary Share | D | D | A | $20.39 |
| AAgilent Technologies Inc. | C | C | B | $135.98 |
| WATWaters Corp | D | C | B | $378.16 |
| ILMNIllumina Inc | D | D | A | $164.40 |
| MTDMettler-Toledo International | D | C | C | $1183.57 |
| RVTYRevvity, Inc. | C | D | B | $100.52 |
| BRKRBruker Corporation | D | D | A | $58.44 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $305.46 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.19 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $29.59 |
About
Prenetics Global Ltd is a diversified health sciences company operating three consumer healthcare brands: IM8 (a fast-growing supplement brand), Europa (sports distribution in the USA), and CircleDNA (direct-to-consumer DNA testing). The company has established a Bitcoin treasury with an initial approximately $20 million investment and a board-approved comprehensive digital asset strategy, positioning itself at the intersection of healthcare innovation and digital assets.